Opto Circuits buys US devices co

Opto Circuits (India) Ltd. | Medical Equipment/Supplies/Accessories | Healthcare | BSE: 532391 | NSE: OPTOCIRCUI

28 Jul 2010 Evaluate

Medical devices company Opto Circuits (India) Ltd, has fully acquired US-based Unetixs Vascular Inc, for a cash consideration of around $9.7 million (around Rs 45 crore at current rate). The acquisition is to be funded through internal accruals.

Unetixs makes devices that can diagnose vascular diseases and is a global leader in the manufacture of a device that detects peripheral arterial disease (PAD). Its products are used in physicians' offices, vascular laboratories, hospitals and mobile testing units.

Access to the PAD detection technology of Unetixs Vascular is a key milestone for Opto. It will allow the company to offer to the world diagnostic products from Unetixs and treatment products provided by Eurocor, its European subsidiary.

crack crack

Peers

Company Name	CMP
Lenskart Solutions	706.60
Poly Medicure	1727.75
Molbio Diagnostics	1288.60
Laxmi Dental	197.50
GKB Ophthalmics	62.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.